Skip to main content
Equibles
INM logo

INM · InMed Pharmaceuticals Inc. · Share Buybacks

Track INM — free

Use INM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.33 -0.02 (-1.48%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Sep 9, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”
View the 10-K filed Sep 9, 2026
Market Cap
$7.58M
Shares
5.49M
Volume · Oct 2 28.34K Avg daily vol (3M) 916.81K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2022-04-07 — — —
Key facts CIK 1728328 CUSIP 457637700 Visit website Investor relations